Citius Oncology, Inc. CTOR IP Ramp D Milestones Included In License Payable
IP Ramp D Milestones Included In License Payable at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:IPRampDMilestonesIncludedInLicensePayable.
The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s ip ramp d milestones included in license payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s IP ramp d milestones included in license payable?
- Citius Oncology, Inc. (CTOR) reported IP ramp d milestones included in license payable of $7.1M in Q3 2024.
- What does IP ramp d milestones included in license payable mean?
- Represents the portion of future research and development milestone obligations that have been accrued or recognized as a liability within license agreements. This metric tracks the financial commitment associated with achieving specific technical or regulatory progress in licensed intellectual property. It is critical for assessing the company's future cash outflow obligations related to its R&D pipeline.